Folan L A, Tuttle K R
The Heart Institute of Spokane, Spokane, WA, USA.
Minerva Med. 2004 Oct;95(5):385-94.
Diabetic nephropathy is a disease entity that is becoming more prevalent in the developed world. Its effect on individuals and society is profound, both in terms of cost and on patient health, especially in relation to associated cardiovascular disease. This review is an analysis of the most recent data available on diabetic nephropathy and its clinical applications to patient care. Using Medline search for relevant data from 1983 to the present, it focuses on clinical strategies that are employed to help curtail the progressive nature of this disease. Current strategies, including glycemic control, blood pressure treatment, inhibition of the renin/angiotensin system, nutrition, and hyperlipidemia, are discussed in relation to the relevant clinical data. Current clinical markers and possible future treatments are also discussed in the context of aiming to improve clinical outcomes in patients who are affected.
糖尿病肾病是一种在发达国家日益普遍的疾病实体。它对个人和社会的影响深远,无论是在成本方面还是对患者健康方面,尤其是与相关心血管疾病有关时。本综述分析了有关糖尿病肾病的最新可用数据及其在患者护理中的临床应用。通过使用Medline搜索1983年至今的相关数据,重点关注用于帮助遏制该疾病进展性的临床策略。结合相关临床数据讨论了当前的策略,包括血糖控制、血压治疗、肾素/血管紧张素系统抑制、营养和高脂血症。还在旨在改善受影响患者临床结局的背景下讨论了当前的临床标志物和可能的未来治疗方法。